The GLP-1-Forecast-Key-Predictions-for-2024

The GLP-1 Forecast: Key Predictions for 2024

04/25/2024 Written by: AP Employee Benefits

Watch the Webinar Replay

AssuredPartners on April 25, discussed how the gene and cell therapy market continues to expand and develop targeted solutions for a wide range of diseases such as cancer, heart disease, and rare hematological conditions. During this session, we explored what actions plan sponsors should consider in order to build a long-term comprehensive management strategy for these therapies.

Watch the recorded webinar below.

Looking for more insights? Contact our Employee Benefits team today.

Contact us

Featured News & Insights

Mid-Year-Employee-Benefits-Compliance-Round-Up
2025 Mid-Year Employee Benefits Compliance Round Up
Webinar07/15/2025
employee-benefits compliance video

Watch the Webinar Replay In this webinar, members of the AssuredPartners Compliance team, The Council’s Government Affairs team and legal counsel from Steptoe engage in a panel discussion to provide...

Upcoming
Webinar
Register Here

Beyond-the-Script-Targeted-Pharmacy-Solutions-for-Sustainable-Cost-Control
Beyond the Script: Targeted Pharmacy Solutions for Sustainable Cost Control
Webinar07/08/2025
employee-benefits video

Join Us for a Live Webinar Event Wednesday, July 30, 2025  |  2:00 - 3:00 PM EDT Details As employers work to manage rising pharmacy costs without compromising quality of care, this session will...

Supporting-Maternal-Mental-Health-in-the-Workplace-What-HR-Leaders-Need-to-Know
Supporting Maternal Mental Health in the Workplace: What HR Leaders Need to Know
Webinar06/12/2025
employee-benefits video

Watch the Webinar Replay In this webinar, learn about how HR leaders can better support maternal mental health across the parenthood journey. We’ll cover key topics including perinatal mood and...